Search or ask a question

How to starve cancer leukemia?

Answers from top 3 papers

PDF

Open Access

More filters

Papers (3)	Insight
Journal Article•DOI 7,12-DMBA-induced rat leukemia: a review with insights into future research. Taketoshi Sugiyama, Mitsuhiko Osaka, Kenichi Koami, Sakan Maeda, Norifumi Ueda - Show less +4 more 01 Dec 2002-Leukemia Research 33 Citations	This leukemia will provide an important tool for chemical carcinogenesis and leukemia studies.
Open access•Journal Article•DOI A Phase I Study of Quizartinib Combined With Chemotherapy in Relapsed Childhood Leukemia: A Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study Todd M. Cooper, Jeannette Cassar, Elena Eckroth, Jemily Malvar, Richard Sposto, Paul S. Gaynon, Bill H. Chang, Lia Gore, Keith J. August, Jessica A. Pollard, Steven G. DuBois, Lewis B. Silverman, Javier Oesterheld, Guy Gammon, Daniel Magoon, Colleen Annesley, Patrick A. Brown - Show less +16 more 15 Aug 2016-Clinical Cancer Research 54 Citations	Toxicities were consistent with intensive relapsed leukemia regimens.
Journal Article•DOI Design of colloidal drug carriers of celecoxib for use in treatment of breast cancer and leukemia. Melike Üner, Gülgün Yener, Mine Erguven - Show less +2 more 01 Oct 2019-Materials Science and Engineering: C 21 Citations	Thus, they are able to be administered efficaciously alone and in combination therapies in remedy of breast cancer and acute promyelocytic leukemia.

My columns

Related Questions

What are the nutritional guidelines for cancer patients ?4 answersNutritional guidelines for cancer patients include regular screening for malnutrition, individualized counseling by a dietitian, achieving adequate caloric and protein intake, correcting vitamin and mineral deficiencies, considering fish oil or long-chain N-3 fatty acid supplements, and engaging in physical activity. The Malnutrition Screening Tool (MST) can be used for screening. Several organizations worldwide have published clinical practice guidelines (CPGs) on nutrition support for cancer patients. The ESPEN guidelines on nutrition in cancer patients have been transformed into flow charts for easier use in clinical practice. The 2021 ESPEN Practical Guidelines for Nutritional Support in Oncology provide recommendations for nutritional support, including screening for nutritional deficiencies, modifying the diet, prescribing additional nutrition (mainly enteral), and emphasizing the need for physical activity. Malnutrition in cancer patients leads to prolonged hospitalizations, increased treatment-related toxicity, reduced response to treatment, impaired quality of life, and worse prognosis. Efforts are being made to improve nutritional care in oncology, but more concrete actions and participation from scientific societies and health authorities are needed.

Cancer recovery with food5 answersCancer recovery can be supported through the use of specialized formula foods that provide balanced nutrition and additional components to enhance immunity and promote overall health. These formula foods are designed to address the specific nutritional needs of cancer patients during the recovery phase. They often include ingredients such as plant proteins, collagen peptides, whey protein, fats, carbohydrates, vitamins, and minerals. These foods can help improve intestinal absorption, regulate spleen and stomach function, promote cell apoptosis, relieve side effects of treatments, and enhance liver regeneration. Patients prefer to receive relevant and prescriptive guidance on food-related information from healthcare practitioners and paper-based channels. However, further research is needed to better understand cancer survivors' perceptions of food-related information and to develop effective food safety messages for this population..

Can leukemia patients eat chicken?6 answers

How do you induce leukemia in mice?6 answers

How to increase WBC count in leukemia?2 answers

What can you eat during chemo for lung cancer?4 answers

See what other people are reading

What happen if dvl is overexpressed?

Overexpression of Dvl (Dishevelled) has been shown to have significant effects in different contexts. In the case of hepatocellular carcinoma (HCC), Dvl2 overexpression is associated with increased cell migration and invasion, indicating a role in cancer progression and poor prognosis. In plant development, overexpression of DVL genes leads to severe alterations, particularly in socket cell recruitment and differentiation, suggesting a role in local signaling for cell fate determination. Moreover, in colorectal cancer (CRC), DVL1 overexpression is linked to liver metastasis, making it a potential prognostic marker for CRC patients. Additionally, in Arabidopsis, overexpression of DVL1 results in pleiotropic phenotypes affecting plant stature, leaf morphology, and fruit development, indicating a role in regulating plant growth and development.What are the potential risks and complications associated with abnormalities in the production or function of red blood cells?

Abnormalities in red blood cell (RBC) production or function can lead to various risks and complications. These include vascular dysfunction, inflammation, and endothelial damage. Such abnormalities can impact blood rheology, causing issues like hypertension, stroke, and cardiovascular diseases. Moreover, misshapen RBCs may be more susceptible to osmotic and mechanical stress, affecting their survival and function, potentially exacerbating conditions like neurodegenerative diseases. Additionally, anemia has been linked to severe cardiovascular complications such as bleeding, thromboembolic events, and hypertension, particularly in elderly patients. These complications highlight the critical role of RBC abnormalities in various health conditions and emphasize the importance of understanding and managing hematologic abnormalities in clinical settings.Does all bitter medicinal plant cure liver diseases?

Not all bitter medicinal plants cure liver diseases, but many have shown hepatoprotective effects. Various medicinal plants contain compounds like flavonoids, alkaloids, and phenols that exhibit hepatoprotective properties against liver diseases. Some plants like Picrorrhiza kurroa, Andrographis paniculata, and Phyllanthus amarus have been found to be active against certain hepatotoxins and even Hepatitis B virus. Over 300 preparations in Indian medicine and 600 herbal formulations globally claim hepatoprotective activity, with identified phytochemicals that can be developed into single-ingredient drugs. However, the efficacy of herbal products can vary due to natural factors, necessitating thorough pharmacological validation for each plant's efficacy against liver diseases induced by different agents.What is the current scenario breast cancer?

The current scenario of breast cancer involves a complex landscape influenced by various factors. Breast cancer is the most common cancer in women globally, with increasing incidence and mortality rates over the years due to changing risk factors and better detection. The disease is highly heterogeneous, requiring tailored treatment strategies based on molecular features like HER2 status, hormonal receptors, gene mutations, and immune markers. During the COVID-19 pandemic, challenges in managing breast cancer care emerged, impacting patient outcomes due to delayed diagnoses and treatment. Innovations in precision medicine offer personalized treatment approaches, including targeted therapies and immunotherapy, for different subtypes of breast cancer. Early detection through novel technologies and theranostics is crucial for improving survival rates and patient outcomes. Efforts are needed to address disparities in breast cancer management globally and enhance diagnostic and treatment capabilities to control mortality rates.What is the recommanded treatment of molecular relapse of NPM1 acute myeloid leukemia?

The recommended treatment for molecular relapse of NPM1-mutated acute myeloid leukemia (AML) involves utilizing venetoclax (VEN) in combination with azacitidine (AZA) as a bridge-to-transplant strategy. This approach has shown efficacy in preventing overt relapse, achieving deep responses, and preserving patient fitness before hematopoietic stem cell transplantation (HSCT) in NPM1mut AML patients with measurable residual disease (MRD). Patients in molecular relapse or persistence achieved complete remission with negative MRD status after VEN-AZA treatment, leading to successful HSCT outcomes with high rates of survival and MRD negativity. Additionally, the use of high-dose cytarabine-based salvage chemotherapy has shown promising responses in patients relapsing during or after chemotherapy, emphasizing the importance of disease burden and timing of relapse in guiding treatment decisions for NPM1mut AML.How many times is ITGB1 palmiytoylayted?

ITGB1, also known as Integrin β1, plays crucial roles in various cellular processes in different conditions. While the exact number of times ITGB1 is palmitoylated is not explicitly mentioned in the provided contexts, the research papers shed light on the significance of ITGB1 in different contexts. ITGB1 has been associated with promoting chondrogenic differentiation of adipose-derived mesenchymal stem cells, contributing to the malignancy of gastric cancer through the Src-mediated FAK/PI3K/Akt signaling pathways, and selectively activating the PI3K/AKT signaling pathway in medulloblastoma cells. These studies highlight the diverse roles of ITGB1 in various diseases and cellular processes, emphasizing its importance as a potential therapeutic target.How many new cases of cancers and deaths reported anually?

Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States. In 2023, it is projected that there will be 1,958,310 new cancer cases and 609,820 cancer deaths. Similarly, in 2022, there were 1,918,030 new cancer cases and 609,360 cancer deaths. In 2021, the estimates were 1,898,160 new cancer cases and 608,570 cancer deaths. Furthermore, in 2020, there were 1,806,590 new cancer cases and 606,520 cancer deaths. These statistics highlight the ongoing efforts to track and understand the incidence and mortality rates of various types of cancer in the United States, aiding in the development of targeted interventions and treatments to combat this significant public health challenge.How many new cancer cases are reported in 2023?

In 2023, a total of 1,958,310 new cancer cases are projected to occur in the United States. Additionally, France is expected to see 433,136 new cancer cases in the same year, with increases of 98% for men and 104% for women. In Brazil, an estimated 704,000 new cancer cases are expected for the triennium 2023-2025, with breast cancer and prostate cancer being the most incident types. Specifically, colorectal cancer is anticipated to contribute to approximately 153,020 new cases in the United States in 2023. These projections highlight the significant burden of cancer globally and the importance of continued efforts in prevention, early detection, and treatment to combat this widespread disease.What is the prevalence of breast cancer all over the world?

Breast cancer is a significant global health concern, with an estimated 2.3 million new cases and 685,000 deaths in 2020 alone, making it the most frequently diagnosed cancer and leading cause of cancer death in females worldwide. The burden of breast cancer varies widely among countries, with incidence rates ranging from 5/100,000 in Bhutan to 113.2/100,000 in Belgium, and mortality rates varying from 2.7/100,000 in Bhutan to 36.9/100,000 in Fiji. The global incidence of breast cancer increased to 1,960,681 cases in 2017, with a notable rise in lower social-development index (SDI) countries, while higher SDI countries experienced a relieving burden. These statistics highlight the pressing need for increased health awareness, prevention strategies, and improved access to medical treatment to address the escalating prevalence of breast cancer worldwide.Is starvation mode real?

Starvation mode is a real physiological state observed in various organisms. In the context of bacterial growth, starvation-survival occurs when there is an insufficient amount of nutrients, particularly energy, for growth and multiplication. In cancer treatment, short-term starvation or fasting can trigger a protective mode in normal cells, inhibiting growth signals, while cancer cells remain unaffected due to mutations, a phenomenon known as differential stress resistance (DSR). Moreover, under severe nutrient shortage, bacterial growth models exhibit metabolic 'shut down' responses as a survival mechanism. These instances highlight the existence and significance of starvation mode in different biological contexts, emphasizing its impact on cellular behavior and survival strategies.How was pik3ca status determined in solar 1 trial?

In the SOLAR-1 trial, the determination of PIK3CA status was carried out using PCR-based assays on tumor tissue samples. The study included postmenopausal women and men with hormone receptor-positive, HER2-negative advanced breast cancer. PIK3CA mutations were detected in approximately 40% of patients, with the most prevalent mutations found in exon 20 (H1047) followed by E545, E542K, C420R, and Q546. The analysis involved utilizing archival tumor tissue and fresh biopsies from the participants, with a focus on detecting mutations in hotspots in exons 7, 9, and 20, which are common in hormone receptor-positive breast cancer and sensitive to the PI3K inhibitor alpelisib. This approach allowed for the identification of specific PIK3CA mutations in the enrolled patients, providing valuable insights into the prevalence and distribution of these mutations in the study population.